2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine,
basimglurant,
RO4917523,
Basimglurant,
802906-73-6,
RG7090,
RG-7090,
UNII-3110E3AO8S,
RO-4917523,
2-Chloro-4-((1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-yl)ethynyl)pyridine,
Ro4917523,
3110E3AO8S,
CTEP Derivative,
2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethylimidazol-4-yl]ethynyl]pyridine,
Basimglurant [USAN:INN],
RG 7090,
RO 4917523,
Basimglurant (USAN/INN),
RG7090 (CTEP Derive),
SCHEMBL560590,
GTPL9309,
CHEMBL3301626,
UPZWINBEAHDTLA-UHFFFAOYSA-N,
AOB87349,
BCP15864,
ZINC6716839,
BDBM50071374,
MFCD25976719,
RG7090 pound Basimglurant pound(c),
compound 2 [PMID: 25565255],
CS-3388,
DB11833,
2-Chloro-4-(2-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-yl)ethynyl)pyridine,
Pyridine, 2-chloro-4-(2-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-yl)ethynyl)-,
NCGC00390716-02,
AK171450,
AS-51978,
HY-15446,
D10864,
1-(4-Fluorophenyl)-4-[(2-chloro-4-pyridyl)ethynyl]-2,5-dimethyl-1H-imidazole,
2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine,
D04QKU,
CID11438771,
Antidepressant (oral), Hoffmann-La Roche,
B4808,
MGluR5 antagonist (depression/fragile X syndrome, oral), Roche,
2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethyl-imidazol-4-yl]ethynyl]pyridine,